Breast Milk Bank Helps Babies Thrive In Nepal
Hundreds of newborns receive the nourishment they need to survive and thrive through a program in Kathmandu supported by UNICEF, the government of Nepal and other partners. But plans to expand the services and reach more babies in need are on hold due to funding cuts.
New mother Sarita Khatri Tamang rests with her newborn baby in the Kangaroo Mother Care ward at the UNICEF-supported Paropakar Maternity and Women's Hospital in Kathmandu.
© UNICEF/UNI792286/Upadhayay
New mother Sarita Khatri Tamang holds her baby close as she lies in a bed recovering from a C-section delivery at Paropakar Maternity and Women's Hospital in Kathmandu.
She has been unable to breastfeed, but her baby is not missing out on the breast milk needed for optimal infant nutrition. Thanks to the hospital's Amrit Kosh — Nepal's first human milk bank — she is able to receive breast milk donated by other mothers.
"At a time when I could barely stand up because I was in so much pain," Tamang says, "it was such a big support for me."
The milk bank is part of a comprehensive lactation management center established in 2022 by the government of Nepal, with support from the European Union and UNICEF. The center ensures proper nourishment for newborns in critical condition, including many born prematurely. Around 500 babies are supported every month with donated breast milk — the next best thing to a mother's own milk.
Plans to open or expand similar lactation management units in hospitals across Nepal, particularly in facilities serving large numbers of at-risk newborns, have been put on hold due as recent funding cuts have affected UNICEF's ability to support these initiatives. Funding cuts have also disrupted other key UNICEF-supported services including breastfeeding support and counseling.
"The demand is still much higher than what the bank can currently supply on a daily basis," says Dr. Kalpana Upadhyaya Subedi, Chief Consultant Pediatrician and head of the Department of Neonatology at Paropakar. 'Expanding such facilities across the country would ensure that more mothers and babies receive the support they need, reducing neonatal mortality and promoting healthier outcomes for future generations."
Breastfeeding is the best form of nutrition for babies, especially for the first six months of life. But breast milk is more than a meal. It also plays a critical role in protecting vulnerable infants from infections and malnutrition.
On May 2, 2025, Dr. Smriti Poudel counsels new mother Sarita Khatri Tamang at the Paropakar Maternity and Women's Hospital in Kathmandu, where UNICEF supports Nepal's first Human Milk Bank. Expansion plans are on hold due to funding cuts.
© UNICEF/UNI792463/Rabik Upadha
Nepal faces significant challenges in early childhood nutrition. One in 4 children under age 5 is stunted, and 8 percent are wasted, with limited access to treatment, according to UNICEF. Nearly half of all infants are not exclusively breastfed, and over 1 million children suffer from anemia.
'It makes me happy to think that because of me, lives were saved.'
Sushila Nagarkoti is one of the mothers who has donated to the Kathmandu milk bank. "The nurse told me that I was producing a lot of milk and asked if I wanted to donate some; I said okay, since I had more than enough milk for my own child," Nagarkoti says. "It makes me happy to think that because of me, lives were saved."
Learn more about UNICEF programs in Asia
Your contribution to UNICEF is more important than ever. Please donate.
Right now, the lives of the most vulnerable children hang in the balance as conflicts and crises jeopardize the care and protection that they deserve. Dependable, uninterrupted and effective foreign aid is critical to the well-being of millions of children. Please contact your members of Congress and urge them to support ongoing U.S. investments in foreign assistance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Iranians saw America as better friend than Russia before war: Official
(NewsNation) — Iran's Health Ministry spokesman told NewsNation that Iranians viewed America as a better friend than Russia before President Donald Trump backed Israel's attacks. 'There was no perception about America prior to this. Some didn't like America, some had no opinion, and some considered America a better friend than Russia,' spokesman Hossein Kermanpour in an interview with NewsNation. A week into their war, Israel and Iran exchanged more strikes Friday as new diplomatic efforts led by the Europeans took place in Geneva. Kermanpour said Iranians were 'very surprised' by Trump and European support for the Israeli operation, adding that it confirmed suspicions that 'America is not to be trusted.' He said the strikes came 'in the midst of fruitful negotiations.' Iran nuclear weapons claims: What we know and what we don't However, he said that Iranians do not support U.S. involvement in the conflict with Israel following the recent strikes. Iran's Health Ministry reported more than 3,000 people injured in Israeli strikes, with 90% being civilians, and about 400 killed, according to Kermanpour. Kermanpour said about 2,000 of the injured have been treated and discharged. The casualties include a 2-month-old baby who was killed and a 4-year-old boy among the wounded, making them the youngest victims and injured, respectively. The Health Ministry spokesman said the attacks occurred 'while the people were sleeping' and targeted 'more than ten provinces of the country, including Tehran,' killing what he described as 'a significant number of civilians and military,' calling them 'martyrs.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 hours ago
- Yahoo
These may be the 3 most effective non-drug ways to treat knee arthritis
A knee brace appears to be one of the more effective ways to treat the pain - as well as improve function and stiffness - from osteoarthritis, the common degenerative process where the cartilage cushioning the joint deteriorates over time. Researchers in China ranked the relative effectiveness of a dozen treatments, ranging from laser and ultrasound therapy to wedged insoles and kinesiology tape, studied in 139 randomized controlled trials. Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Based on the results from 9,644 participants, the simple knee brace ranked highest in effectiveness to alleviate symptoms of arthritis, the researchers concluded. However, 'the challenge,' said Prakash Jayabalan, the director of musculoskeletal research at the Shirley Ryan AbilityLab in Chicago, 'is getting patients to actually wear knee braces.' Jayabalan and other clinicians who weren't involved in the study said knee braces can provide certain people immediate relief by supporting the load on the joint. But, some patients find braces uncomfortable to wear. Hydrotherapy and exercises such as weightlifting and yoga placed second and third in the meta-analysis ranking. Hydrotherapy, also known as water exercises or aquatherapy, is a treatment approach designed to improve symptoms. And experts said staying active and maintaining a healthy weight are the most effective ways to relieve symptoms of knee osteoarthritis. 'Both of those can improve symptoms and slow the progression of arthritis,' said Morgan Jones, a sports medicine orthopedic surgeon at Mass General Brigham. The peer-reviewed study published in PLOS One on Wednesday. It was led by Yuan Luo, a researcher in the department of rehabilitation at the First People's Hospital of Neijiang, China, who did not respond to questions by the time of publication. - - - What causes knee osteoarthritis? When cartilage in the knee breaks down, the joint is left with 'bone on bone motion,' Jayabalan said. Cartilage can't repair itself like other tissues in the body and, oftentimes, people don't know they've lost the cartilage in their knee until it's gone, he said. There are two common risk factors for knee arthritis - a previous knee injury such as an ACL tear and unhealthy weight gain, said Steve Messier, the director of the J.B. Snow Biomechanics Laboratory at Wake Forest University. Every pound of additional body weight amounts to four pounds of stress on the knees when a person is walking, Messier said. Once someone has arthritis in their knee, they need to make broad lifestyle changes with regular exercise to manage the pain, he said. 'It really doesn't matter what type of exercise you do, just so you're being active,' Messier said. 'They all will reduce pain.' Other clinicians agree staying active is one of the best ways to relieve knee arthritis pain. It's the first recommendation in guidelines published in 2019 from the Osteoarthritis Research Society International. Around 33 million U.S. adults have osteoarthritis, according to the Centers for Disease Control and Prevention. People commonly take NSAIDs such as ibuprofen to relieve the symptoms. But, these pain-relievers can damage the lining of your gut. Jayabalan said he recommends people use NSAIDs for no more than 10 days when they're experiencing 'debilitating pain' that is impacting their function. 'You should not be taking these every day,' he said. Knee replacements have long been the gold standard for damaged joints, but it can take up to a year for some people to fully recover from surgery. Emerging alternatives target the nerves to stop the knee pain and block blood flow to reduce inflammation. 'Two people can have the same amount of structural damage in their knee and have totally different pain profiles,' said Jones, also an assistant professor of orthopedic surgery at Harvard Medical School. 'The decision for knee replacement ends up being really individualized, and the focus is on the person's symptoms.' - - - What did the study find? The knee brace ranked best on various scores of pain, stiffness and function, and had the 'highest probability of being the best technique,' the researchers wrote. Jones said a knee brace can be 'very effective' in people who have arthritis in certain compartments of the knee because the brace can shift the load to another part of the joint. 'But, if somebody has arthritis throughout their knee, an unloader brace is not as likely to be helpful,' he said. 'They don't have a more-normal area to off-load the force to.' The researchers compared a dozen interventions: low-level laser therapy, high-intensity laser therapy, transcutaneous electrical nerve stimulation, interferential current, short wave diathermy, ultrasound, lateral wedged insole, knee brace, exercise, hydrotherapy, kinesio taping and extracorporeal shock wave therapy. Hydrotherapy ranked second in some scores. Water buoyancy takes pressure off the knee joints and helps improve range of motion for some people, Jayabalan said. Ultrasound pulse therapy to treat knee arthritis 'remains contentious' and performed the worst across multiple scores, the researchers wrote. And, they concluded that wedged insoles, which attempt to shift the load on the knee by lifting one side of the foot, did not 'outperform neutral devices in pain reduction.' Insoles used to be a popular therapy for knee osteoarthritis but 'multiple studies' have shown they don't help, Jones said. - - - The study's limitations Many of the studies in the meta-analysis are short, six to 12 weeks, Messier said. Therefore, the results support only short-term pain relief from these treatments. 'It may relieve pain for a little while, but it's not going to change pain in the long run,' Messier said. 'The most effective thing they have here is exercise.' Jayabalan said none of the studies are looking at whether the treatments led to mechanistic improvements in the knee - 'they were not regrowing cartilage, or something like that.' Instead, the studies recorded clinical observations that these treatments may provide a potential benefit. And, many of the randomized controlled trials were conducted on small groups of participants, Jones said. 'There's a lot of variability in the studies and how long they follow their patients,' he said. Related Content 3-pound puppy left in trash is rescued, now thriving How to meet street cats around the world 'Jaws' made people fear sharks. 50 years later, can it help save them?
Yahoo
7 hours ago
- Yahoo
Biotech industry faces off: US vs. China
China has become a significant player in the biotech space, potentially threatening the lead the US holds. EY Americas industry markets leader for health sciences and wellness Arda Ural sits down with Josh Lipton and Yahoo Finance Senior Reporter Anjalee Khemlani to discuss the dynamics between the US and China in the biotech industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here According to a recent report from the Harvard Belfer Center for Science and International Affairs, China has the most immediate opportunity to overtake the United States in biotechnology. For more, let's welcome in Arta Rawi America's industry markets leader and Health Sciences and wellness, as well as Yahoo Finance's very own Anjali Camlani. Welcome to you both. All right, I'll start with you. Uh, maybe it's just a big question, big picture question. Does the US have the investment power, in your opinion, to overtake China in biotech? Yeah, thanks for having me. Uh, the biotech is the innovation feeder to the big pharmaceuticals and it only uh nurtures well in an ecosystem. So to answer your question, what do you need in that ecosystem for that to nurture? Uh, investment capacity, which we have been having for the last, you know, decades, if you will, to kind of keep investing in that innovation to move on. NIH has been probably the world's largest VC over $40 billion in non-dilute funding into the entrepreneurial startups. Then you have talent who has been, you know, coming all these top universities and MDs and PhDs who are dedicated to advance it. And then you need this technology transfer system so that those intellectual property translate into a startup. And then with that investment capacity, it keeps growing and then through testing and going to the humans and then ultimately being developed for everyone's use. So, uh, yes, the US still has the capacity to invest, but it is not potentially the only game in town given the development coming from China. I'm curious, Arta, because we know, I know you've been tracking the deals and uh, we've seen the number of deals steadily increasing over the years. I saw, uh, one of the ones that you sent, which looks at the number of deals so far to date for 2025 is more than half of what we saw in 2024. So we can expect that to really outpace 2024. What does that mean though? Because I know that some of the deals that are happening are more, um, what you would call licensing deals, right? It's not necessarily that this money is going to from scratch investment and innovation, but it's more stuff that has already happened and is built up. Talk to me about that and why that matters. I mean, first of all, the numbers are pretty compelling. A couple years ago, we had pretty much like no deals under a billion dollars in 2016. And as of last year, there were $30 billion worth of licensing deals from Chinese assets into the US, and 2025 is a very strong start, so they're definitely going to beat that number. So the reason why this is happening is in 2015, Chinese Communist Party put a priority of investing in biotech and that was a priority sectors. And it was 10 years ago, and that 10 years of journey started to play out for their benefit because China historically has been known for this active product ingredients and excipients, which is like the chemicals that pharmaceuticals were using to make small molecule products. And that journey now is taking them to upstream to more advanced innovation. Probably we still have not seen a first in class, but clearly they are going for best in class, like those are the shots on goal if you are seeing more and more. Well, that's why, that would be my question because I know that we've seen sort of they're doing copycats or metoos in terms of the type of innovation coming out of China. Um, do we expect that they have the wherewithal to outdo the US then in that sense, in terms of coming up with the next blockbuster for the entire world? I mean, there are a couple examples, early examples that some of the Chinese based assets actually head-to-head comparisons, you know, beat or exceed, at least match the efficacy and safety profile of some of the Western developed compounds. But this is also a journey as the audio question. So what is it, what do they need more to get there? So they have the talent. I mean a lot of Western educated MDs and PhDs went back to China working on that. The government itself as a part of prioritization program have been investing in it. So then the question is, do they have an exit strategy for those entrepreneurs? And that I think is where they are lacking because there's no like an IPO market that is comparable to the Western standards. There's no like an M&A exit until recently. I think that's where the weakness kind of may be the opportunity for them to come up. But the deals we were talking about, they're because of the intellectual property concerns, because of the concerns of reliability and trust in the data because, you know, there's no such institution in the world like FDA that everyone trusts and hopefully continue to trust. And for that reason, the deals seem to be more asset purchases. So I'm not taking a risk by operating in China, but I'm buying the asset and in a licensing deal, and I'll continue to develop it, especially if you can make this cheaper and faster in China, which has been their competitive advantage over the Western companies, then you bring that into a human fast and then the human testing can be done, validations can be done in the more Western setting. I think that can be a winning formula for the industry. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
